Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-03

Clinical Trial Update: [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating [F-18] Fluorothymidine (FLT) imaging in patients with primary brain tumors; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • [F-18] Fluorothymidine (FLT)

Snippet

Sponsor: University of Utah | Conditions: Cancer, Brain Tumors | Phase 1 | Status: COMPLETED | Results posted: 2016-02-03